MDLZNEUTRAL

Return on Equity (ROE)

10.2%

Updated 56h ago

Sector Performance

38th percentile

MDLZ

10.2%

Sector Median

13.8%

Sector Avg

31.4%

📊

Deep Analysis

Return on Equity (ROE) measures how efficiently a company generates profit from the money shareholders have invested — a 10.2% ROE means MDLZ earns $0.102 for every dollar of equity.

This sits below the sector median of 13.8%, placing MDLZ in the 38th percentile among sector peers, indicating below-average profitability relative to competitors. The metric currently has no trend data: year-over-year change is N/A, quarter-over-quarter change is N/A, and the last eight quarters show no directional history. With a below-median level and no trend to assess improvement or deterioration, the opportunity is unclear — the lack of change history offers no signal for recovery or further weakness. This neutral-to-weak level combined with absent trend data neither supports nor contradicts the overall NEUTRAL verdict, as the single data point is consistent with a hold position.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about MDLZ?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are MDLZ's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.